SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-014581
Filing Date
2021-06-16
Accepted
2021-06-16 17:15:34
Documents
19
Period of Report
2021-06-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29663
2 ex99-1.htm EX-99.1 14327
3 ex99-1_001.jpg GRAPHIC 81674
4 ex99-1_002.jpg GRAPHIC 231046
5 ex99-1_003.jpg GRAPHIC 198396
6 ex99-1_004.jpg GRAPHIC 158551
7 ex99-1_005.jpg GRAPHIC 177971
8 ex99-1_006.jpg GRAPHIC 141137
9 ex99-1_007.jpg GRAPHIC 199936
10 ex99-1_008.jpg GRAPHIC 147363
11 ex99-1_009.jpg GRAPHIC 157988
12 ex99-1_010.jpg GRAPHIC 131478
13 ex99-1_011.jpg GRAPHIC 191384
14 ex99-1_012.jpg GRAPHIC 147012
15 ex99-1_013.jpg GRAPHIC 148248
16 ex99-1_014.jpg GRAPHIC 200013
17 ex99-1_015.jpg GRAPHIC 126389
18 ex99-1_016.jpg GRAPHIC 146687
19 ex99-1_017.jpg GRAPHIC 80343
  Complete submission text file 0001493152-21-014581.txt   3717732
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 211022329
SIC: 2834 Pharmaceutical Preparations